Novo Nordisk (NVO) Stock Price
$54.33 1.1%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
8 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Novo Nordisk, AI stock picks, stock alerts and much more.
NVO AI Stock Analysis
Financial Performance
Novo Nordisk has shown strong financial performance in the last quarter with revenue up by 20.2% from the previous quarter and up by 31.1% year over year to $85.7B. The gross profit also increased significantly, up by 21.1% from the previous quarter and up by 31.1% year over year to $72.7B, indicating a healthy margin expansion for the company.
The operating income was at $36.7B, showing an increase of 8.3% from the previous quarter and a rise of 13.3% YoY, which suggests efficient operations management within the company.
The EBITDA ratio stood at a decent level of .47 implying that Novo Nordisk is generating satisfactory earnings before interest, tax, depreciation and amortization.
Stock Price
The stock price has been on a downward trend as it's currently trading at $47.28, down -29.7% in the last month and -62.5% YoY which might raise concerns among investors regarding its short-term performance.
However, technical indicators such as RSI value (22.75) suggest that the stock could be oversold and may rebound soon while its PE ratio stands at 12.95 which indicates reasonable valuation levels compared to its earnings per share (EPS) of $3.65.
Alternative Data Signals
Negative trends are observed when looking at alternative data signals such as website traffic which is down by -6..3%, MoM and -20.% YoY along with job postings that have decreased by -13.% MoM and -18.% YoY.
However, the company shows strong social media presence with increasing followers across Twitter, Instagram and Facebook. The employee business outlook remains quite positive at 81%, despite a slight decrease YoY.
Conclusion
In conclusion, despite the short-term decline in stock price and some negative trends in alternative data signals like website traffic and job postings, Novo Nordisk's strong financial performance, reasonable valuation levels and positive business outlook suggest that it has potential for recovery making its stock neutral from an investment perspective.
Note: This AI Stock Analysis is based on data as of August 05. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Novo Nordisk (NVO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novo Nordisk (NVO), currently trading at $54.33, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NVO
-
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.
-
Symbol
NVO
-
Market
NYSE
-
Industry
Biotechnology
-
Market Cap
241.4B
Similar Stocks
 |
Zymeworks ZYME |
$13.96 0.7% |
6 |
 |
Ginkgo Bioworks Holdings DNA |
$12.26 11.2% |
3 |
 |
Arcus Biosciences RCUS |
$10.11 3.4% |
5 |
News
NVO Alternative Data
Web Traffic
Novo Nordisk receives an estimated 765621 monthly visitors to novonordisk.com.
-
Web Traffic
765621
-
Change from Previous Month
26.7%
-
3 Month Change
18.6%
-
YoY Change
18.6%
Twitter Followers
Novo Nordisk has 52,160 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.5% over the last month.
-
Twitter Followers
52160
-
Daily Change
0.1%
-
1 Month Change
1.5%
-
3 Month Change
2.7%
-
YoY Change
2.7%
Facebook Engagement
Novo Nordisk has engaged 75,341 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
75341
-
Daily Change
3.4%
-
1 Month Change
452.6%
-
3 Month Change
414.8%
-
YoY Change
414.8%
Instagram Followers
Novo Nordisk has 149,687 Instagram Followers on its main Instagram account, up by 1.3% over the last month.
-
Instagram Followers
149687
-
Daily Change
0.1%
-
1 Month Change
1.3%
-
3 Month Change
4.9%
-
YoY Change
4.9%
Youtube Subscribers
Novo Nordisk has 41,800 subscribers on its main Youtube channel, up by 1% over the last month.
-
Youtube Subscribers
41800
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
2%
-
YoY Change
2%
Job Postings
Novo Nordisk has an estimated 448 open job postings, which is down -50.2% over the last month.
-
Job Postings
448
-
Daily Change
4.3%
-
1 Month Change
50.2%
-
3 Month Change
49.7%
-
YoY Change
49.7%
LinkedIn Employees
According to LinkedIn, Novo Nordisk has 66,898 employees, up by 0.7% over the last month.
-
LinkedIn Employees
66898
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
1%
-
YoY Change
1%
Reddit Mentions
Novo Nordisk has been mentioned an estimated 74 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
74
-
Daily Change
2.6%
-
1 Month Change
469.2%
-
3 Month Change
2366.7%
Reddit Sentiment
The sentiment Score for Novo Nordisk is 66 out of 100, which represents a bullish sentiment.
-
Reddit Sentiment
66.4314
-
Daily Change
7.5%
-
1 Month Change
5.1%
-
3 Month Change
34.4%
Business Outlook
According to employee reviews, the business outlook among employees at Novo Nordisk is 81 out of 100 (very bullish).
-
Business Outlook
81
-
Change from Previous Month
0%
-
3 Month Change
2.4%
-
YoY Change
2.4%
LinkedIn Followers
2,310,547 are following Novo Nordisk on LinkedIn.
-
LinkedIn Followers
2310547
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Novo Nordisk was mentioned 14 times in the news yesterday.
-
News Mentions
14
-
Daily Change
12.5%
-
1 Month Change
0%
-
3 Month Change
0%
NVO Financials
NVO Key Metrics
-
Total Revenue
DKK85.7B
-
Net Income
DKK28.2B
-
Earnings per Share
DKK6.34
-
Free cash flow
-DKK4.3B
-
EBITDA
DKK40.1B
-
EBITDA Ratio
0.468494
-
Total Assets
DKK465.8B
NVO 2-year Revenue & Income
NVO 2-year Free Cash Flow
NVO Technicals
NVO SMA
NVO RSI
FAQ
What's the current price of Novo Nordisk (NVO) Stock?
The price of an Novo Nordisk (NVO) share is $54.33.
What's the market cap of Novo Nordisk?
The current market cap of Novo Nordisk is 241.4B.
Should I buy or sell NVO?
Novo Nordisk shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Novo Nordisk is better viewed as a hold or accumulate position while waiting for further developments.
Is Novo Nordisk a good investment?
The current analysis of Novo Nordisk's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Novo Nordisk's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Novo Nordisk (NVO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Novo Nordisk stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Novo Nordisk (NVO) that investors often compare it to?
Novo Nordisk (NVO) is often compared to similar stocks such as Zymeworks, Ginkgo Bioworks Holdings and Arcus Biosciences.
What is the forecast for Novo Nordisk's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novo Nordisk's stock price to be around $56.9 in 2026. Starting from the current price of $54.33, this represents a 4.7% change in price, indicating a neutral outlook for the stock.
How to buy Novo Nordisk (NVO) Stock?
Novo Nordisk stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novo Nordisk shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.